# COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

> **NCT05633810** · PHASE3 · RECRUITING · sponsor: **Montreal Heart Institute** · enrollment: 10000 (estimated)

## Conditions studied

- Diabete Type 2
- Cardiovascular Diseases

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Aspirin Placebo
- **DRUG:** Colchicine
- **DRUG:** Colchicine Placebo

## Key facts

- **NCT ID:** NCT05633810
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-21
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05633810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05633810, "COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05633810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*